Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 11:32 a.m.

    📋 Syros Pharmaceuticals, Inc. (SYRS) - Business Combination

    Filing Date: 2022-07-05

    Accepted: 2022-07-05 07:07:06

    Event Type: Business Combination

    Event Details:

    Syros Pharmaceuticals (SYRS) Announces Business Combination Syros Pharmaceuticals (SYRS) has entered into a strategic transaction. Transaction Details:
    • Transaction: million shares of its common stock to TYME stockholders to acquire TYME
    • Deal Value: $190 million
    • Timing: Expected to close the second half of 2022 concurrently with each other

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Syros Pharmaceuticals
    • CIK: 0001556263
    • Ticker Symbol: SYRS
    • Period End Date: 2022-07-03
    • Document Type: 8-K

Search

News categories